Hypopituitarism
Endocrine
Hypopituitarism is treated with 11 medications in our database, including Norditropin, Nutropin AQ NuSpin 10, Nutropin AQ NuSpin 5, Nutropin AQ NuSpin 20, Omnitrope, Macrilen, R-Gene, and 6 more. 7 of these have manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Novo Nordisk, Genentech, Sandoz, Xeris, Pfizer and others. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Hypopituitarism treatment below.
What help exists for Hypopituitarism
11
drugs indexed
7
with copay cards
7
with patient assistance
0
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Hypopituitarism
11 totalNorditropin
somatropin · Novo Nordisk
🎟💙ZOMACTON
somatropin · Ferring
🎟💙Omnitrope
Somatropin · Sandoz
GENOTROPIN
somatropin · Pfizer
🎟💙Nutropin AQ NuSpin 10, Nutropin AQ NuSpin 5, Nutropin AQ NuSpin 20
Genentech
R-Gene
Arginine Hydrochloride · Pfizer
🎟💙SOGROYA
somapacitan-beco · Novo Nordisk
🎟💙Macrilen
Macimorelin acetate · Aeterna Zentaris
Ngenla
somatrogon-ghla · Pfizer
🎟💙Skytrofa
Lonapegsomatropin-tcgd · Ascendis
🎟💙HUMATROPE
Somatropin · Eli Lilly
🎟 = copay card · 💙 = patient assistance program
Prior authorization patterns for Hypopituitarism drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | Yes | — | — |
— Medicare Part D | Yes | — | — |
— Medicare Part D | Yes | — | — |
— Medicare Part D | Yes | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | Yes | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | Yes | — | — |
— Medicare Part D | — | — | — |
Showing 10 of 11 PA rules for Hypopituitarism drugs. View individual drug pages for complete PA detail.